SCHEMBL17629946

SCHEMBL17629946

N#Cc1ccc(-c2ccc(-n3ccnc3)cc2CC(N)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 11/20 0.47
PDE2A O00408 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE3B Q13370 1/20 0.46
PDE1C Q14123 1/20 0.46
PDE3A Q14432 1/20 0.46
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP19A1 P11511 1/20 0.39
CD38 P28907 1/20 0.39
HAT1 O14929 2/20 0.39
EP300 Q09472 2/20 0.39
CYP3A4 P08684 1/20 0.37
BAZ2B Q9UIF8 1/20 0.37
CSF1R P07333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17630010 0.90 ADH5 (0.50) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630020 0.85 ADH5 (0.62) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630062 0.84 ADH5 (0.47) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630102 0.83 PDE2A (0.47) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630146 0.82 PDE2A (0.47) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17643462 0.81 ADH5 (0.52) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17629915 0.81 ADH5 (0.47) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630070 0.79 ADH5 (0.51) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17643465 0.79 ADH5 (0.50) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630120 0.79 PDE2A (0.47) ADH5PDE2APDE1APDE1BPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed